Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab)
Catalog No.
F1586
Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab)
Featured Products
Volociximab (M200) is a human/mouse chimeric IgG4 monoclonal antibody IIA1 that targets integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is the major fibronectin receptor involved in angiogenesis. Volociximab has anti-angiogenic and anti-tumor activities and inhibits the proliferation of human umbilical vein endothelial cells (HUVEC).
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.4 kDa
Dry ice
558480-40-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
M200
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08648 & P05556
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Integrin a5b1 (ITGA5 & ITGB1)
Please avoid freeze-thaw cycles.